Ritonavir-boosted darunavir: a powerful option for treatment-experienced HIV-1-infected patients

Author： Menééndez-Arias Luis   Matamoros Tania   ÁÁlvarez Mar  

Publisher： Future Medicine

ISSN： 1746-0794

Source： Future Virology, Vol.3, Iss.5, 2008-09, pp. : 423-434

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Darunavir/ritonavir − a POWERful option for HIV

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 622, 2011-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite

Darunavir: In Treatment-Experienced Pediatric Patients with HIV-1 Infection

By McKeage Kate   Scott Lesley J.  

Pediatric Drugs, Vol. 12, Iss. 2, 2010-04 ,pp. : 123-131

Adis International

Access to resources Recommend Favorite

The combination of darunavir and ritonavir appears to be effective for treatment-experienced children and adolescents with HIV-1 infections

By  

Inpharma, Vol. 1, Iss. 1625, 2008-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Boosted Tipranavir versus Darunavir in Treatment-Experienced Patients: Observational Data from the Randomized POTENT Trial

By Elgadi Mabrouk M.  

Drugs in R&D, Vol. 11, Iss. 4, 2011-12 ,pp. : 295-302

Adis International

Access to resources Recommend Favorite

Influence of tenofovir, nevirapine and efavirenz on ritonavir-boosted atazanavir pharmacokinetics in HIV-infected patients

By Dailly Eric   Tribut Olivier   Tattevin Pierre   Arvieux Cédric   Perré Philippe   Raffi François   Jolliet Pascale  

European Journal of Clinical Pharmacology, Vol. 62, Iss. 7, 2006-07 ,pp. : 523-526

Springer Publishing Company

Access to resources Recommend Favorite